![ART-hero-image-1920 ART-hero-image-1920](https://artpodcast.expert/hubfs/Podcast/ART-hero-image-1920.jpg)
![The_Logistics_of_a_Clinical_Study_ Scale-Up_Title_Card_d01](https://artpodcast.expert/hs-fs/hubfs/The_Logistics_of_a_Clinical_Study_%20Scale-Up_Title_Card_d01.jpg?width=344&name=The_Logistics_of_a_Clinical_Study_%20Scale-Up_Title_Card_d01.jpg)
The Logistics of a Clinical Study Scale-up
Scaling up from phase 1 to global phase II/III trials to beyond marketing approval has several implications on a sponsor’s commercial strategy. Hear from Rachel Smith, Portfolio Director for Veristat, as she uses our recent work with a biotech company to illustrate the importance of a comprehensive shipping and traceability strategy, tight management of the patient journey, and adoption of a well-conceived protocol and process documentation to support the commercialization strategy.